Clinical Trials
All Clinical Trials - Page 36 of 75
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT03733873N/ACompleted
Study on Chinese and Western Medicine in MNE Children
Desmopressin
- NCT03571516Phase 3Completed
Safety, Efficacy and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel Syndrome
Teduglutide
- NCT04012918Phase 2Unknown
Capecitabine in Combination With Aromatase Inhibitor Versus Aromatase Inhibitors, in Hormonal Receptor Positive Recurrent or Metastatic Breast Cancer Patients, Randomized Controlled Study
Gonadorelin
- NCT03671330Phase 2Completed
Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer.
Gonadorelin
- NCT03361735Phase 2Active Not Recruiting
Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer
Gonadorelin
- NCT03676361Phase 4Withdrawn
To Evaluate the Renal Tubular Function Pre and Post Nephrectomy in Living Donors
Desmopressin
- NCT03648281N/ACompleted
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Denmark and Sweden, as Part of Local Clinical Practice (SURE DENMARK/SWEDEN)
Semaglutide
- NCT03341429Phase 4Completed
Evaluation of Liraglutide 3.0mg in Patients With Poor Weight-loss and a Suboptimal Glucagon-like Peptide-1 Response
Liraglutide
- NCT03572387Phase 2Completed
A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment
Gonadorelin
- NCT03638778Phase 1Completed
Research Study Comparing Different Tablets With the Study Medicine Semaglutide in Healthy Men
Semaglutide
- NCT03632759EARLY_Phase 1Completed
Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1D
Liraglutide
- NCT03455322Phase 4Completed
Norepinephrine Infusion Versus Midodrine & Octreotide in Patients With Hepatorenal Syndrome Type 1.
Octreotide
- NCT03659578Phase 2Completed
Study of Thymosin α1 to Reduce Acute Pneumonia For Bulky None-small Cell Lung Cancer
Thymosin-Alpha-1
- NCT03541928Phase 2Recruiting
Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery
Gonadorelin
- NCT03611582Phase 3Completed
Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle Program
Semaglutide
- NCT03379974Phase 4Completed
Exercise Versus DDAVP in Patients With Mild Hemophilia A
Desmopressin
- NCT04555850Phase 1Completed
A Phase 1b Study of Thymosin Beta 4 in Healthy Volunteers
TB-500
- NCT03591718Phase 1Completed
A Study to Test Different Doses of BI 456906 in Patients With Obesity
Survodutide
- NCT03600480Phase 1Completed
A Research Study of How NNC0174-0833 Taken With Semaglutide Works in People Who Are Overweight or Obese
Semaglutide
- NCT03562091N/ACompleted
Perception of Information and Quality of Life in Neuroendocrine Tumour on Lanreotide Autogel
Lanreotide
- NCT03651765Phase 2/Phase 3Completed
Long Term Extension Trial of Setmelanotide
Setmelanotide
- NCT03596450Phase 4Completed
Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial
Semaglutide
- NCT03596164Phase 3Completed
An Extension Study of Teduglutide in Japanese Participants With Short Bowel Syndrome Who Completed 24 Weeks of Treatment in SHP633-306 or TED-C14-004
Teduglutide
- NCT03663582Phase 3Completed
Study of Teduglutide in Japanese Participants With Short Bowel Syndrome
Teduglutide
- NCT03560336N/ACompleted
A Regulatory Post-marketing Surveillance (rPMS) Study to Evaluate the Safety and Effectiveness of Saxenda®(Liraglutide 3.0 mg) in Obese Patients and Overweight Patients With Obesity-related Comorbidities in Routine Clinical Practice in Korea.
Liraglutide
- NCT04790708N/AUnknown
Peptide Receptor Radionuclide Therapy (PRRT) in Tumors With High Expression of Somatostatin Receptors (Phase 2)
Octreotide
- NCT03562130Phase 4Completed
Characterization of the Long-term Safety, Efficacy, and Pharmacodynamics Revestive® in the Management of Short Bowel Syndrome Pediatric Patients
Teduglutide
- NCT03598075N/ACompleted
Amylin and CGRP Head to Head Provocation in Migraine Without Aura Patients
Pramlintide
- NCT03573908Phase 3Completed
A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Linaclotide
- NCT03529123Phase 3Completed
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India)
Lixisenatide
- NCT03543059N/AUnknown
A Prospective Observational Study About Adjuvant or Neoadjuvant Chemotherapy Related Adverse Effects in Premenopausal Breast Cancer Patients
Gonadorelin
- NCT03565835Phase 2Completed
Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer
Gonadorelin
- NCT03439943Phase 2Completed
Study to Evaluate the Effect of Lixisenatide in Patient With Parkinson's Disease
Lixisenatide
- NCT03571594Phase 1Terminated
A Four-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-5788 in Healthy Adult Volunteers
Octreotide
- NCT03500484EARLY_Phase 1Terminated
Effect of Liraglutide on Neural Responses to High Fructose Corn Syrup in Individuals With Obesity.
Liraglutide
- NCT03456687Phase 1Completed
Effects of Exenatide on Motor Function and the Brain
Exenatide
- NCT03552757Phase 3Completed
Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesity
Semaglutide
- NCT03548987Phase 3Completed
Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
Semaglutide
- NCT03150511Phase 2Recruiting
Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury
Tesamorelin
- NCT01422096EARLY_Phase 1Withdrawn
Effect of Short Term Ovarian Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess
Gonadorelin
- NCT05946148N/ACompleted
Novel Antidiabetic Medications and Their Effect on Liver Steatosis (NAMELS-18)
Dulaglutide
- NCT03555994Phase 2Completed
A Study to Investigate the Effect of MEDI0382 on Hepatic Glycogen Metabolism in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.
Liraglutide
- NCT03547427N/ATerminated
Glucagon Counterregulation in Type 1 Diabetes
Pramlintide
- NCT03512262Phase 3Completed
Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM)
Abaloparatide
- NCT03496298Phase 3Terminated
Effect of Efpeglenatide on Cardiovascular Outcomes
Efpeglenatide
- NCT03512236Phase 1Completed
A Trial to Investigate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BioChaperone® Pramlintide Insulin in Patients With Type 1 Diabetes Mellitus
Pramlintide
- NCT03479762N/ACompleted
In Market Utilisation of Liraglutide Used for Weight Management in the UK: a Study in the CPRD Primary Care Database
Liraglutide
- NCT03498001N/ACompleted
Effects of GLP-1 Agonists on CArdiac Steatosis Evaluated by Magnetic Resonance Imaging
Semaglutide
- NCT04522297N/ACompleted
Nor-epinephrine Versus Midodrine/Octreotide in Patients With Hepatorenal Syndrome
Octreotide
- NCT03270709Phase 1Terminated
Effect of High-Dose Vitamin D3 in Smokers and Non-Smokers With and Without HIV
Ll-37